Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nipro's quarterly finished goods
increased
from Sep. 2025 (円176,947 Mil) to Dec. 2025 (円179,346 Mil) and
increased
from Dec. 2025 (円179,346 Mil) to Mar. 2026 (円182,044 Mil).
Nipro's annual finished goods
increased
from Mar. 2024 (円150,391 Mil) to Mar. 2025 (円170,857 Mil) and
increased
from Mar. 2025 (円170,857 Mil) to Mar. 2026 (円182,044 Mil).
Nipro Inventories, Finished Goods Historical Data
* Premium members only.
The historical data trend for Nipro's Inventories, Finished Goods can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Inventories, Finished Goods of 円182,044 Mil mean?
Nipro (TSE:8086) has a Inventories, Finished Goods of 円182,044 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Nipro and its competitors.
Is Nipro's Inventories, Finished Goods too high?
Nipro's current Inventories, Finished Goods is 円182,044 Mil. Overall, Nipro has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nipro's Inventories, Finished Goods compare to ISRG and BDX?
Nipro's Inventories, Finished Goods of 円182,044 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Devices & Instruments company?
A good Inventories, Finished Goods depends on the Medical Devices & Instruments industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Nipro and its competitors. Nipro's current Inventories, Finished Goods is 円182,044 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nipro stock overvalued right now?
Based on GuruFocus' analysis, Nipro (TSE:8086) is currently considered Fairly Valued. The stock's GF Value™ is 円1,465.84, compared to a current price of 円1,570.00 — trading 7.1% above its estimated fair value. The current Inventories, Finished Goods is 円182,044 Mil. Nipro's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Nipro (TSE:8086), the current Inventories, Finished Goods is 円182,044 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nipro (TSE:8086) Overvalued in 2026?
Based on GuruFocus' analysis, Nipro stock appears to be overvalued.
The current stock price of 円1,570.00 is trading 7.1% above its estimated GF Value™ of 円1,465.84.
GuruFocus considers Nipro to be Fairly Valued.
Key valuation signals for TSE:8086:
Inventories, Finished Goods: 円182,044 Mil
GF Value™: 円1,465.84 vs. price of 円1,570.00 (7.1% above fair value)
No single metric tells the full story. See the TSE:8086 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
72GF Score
Get the complete analysis for TSE:8086
Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:8086 has been successfully added to your 
